Researchanalyst
17.04.2023, Author: André Will-Laudien

Mine construction is fully on track

On the EU list of the most critical metals globally, tungsten appears with a value of 7 on a scale of 0 to 8, ranking higher than iron, cobalt, copper, and titanium. Since the Russian invasion of Ukraine, demand for the rare element has increased again, as tungsten is used as a hardening metal in alloys for the defence and high-tech industries. In 2024, an additional 5% of the world market volume will come from the South Korean Sangdong mine, further contributing to the depleted supply market. This is an important milestone for Almonty Industries.

Read the report


17.04.2023, Author: Stefan Feulner

With two innovations in the billion-dollar market

After a brilliant first quarter and a share price performance of over 210%, the share of the Heidelberg-based portfolio company Altech Advanced Materials is consolidating at a high level. The current correction offers attractive long-term entry opportunities. The Company is considered an innovation leader in anode composite materials for lithium-ion batteries and environmentally friendly stationary energy storage systems based on solid-state sodium aluminum oxide batteries. In the age of the energy transition, which is still in its infancy, the newcomer thus has double game-changer potential.

Read the report


14.04.2023, Author: André Will-Laudien

The IPO of its hydrogen subsidiary Nucera is coming

It is finally happening! The era of nuclear power plants in Germany has come to an end. The new government in Berlin is sticking to the coalition decisions of 2011 and will phase out nuclear power by April 15, 2023. Because of the current energy crisis, there had been a small extension, but now it is over. According to announcements by the governing Green Party, Germany will be able to generate its energy entirely from renewable sources, with nuclear energy and fossil-fuel power generation giving way to sustainable wind, solar and hydroelectric power plants. Hydrogen is to be a new addition to the game. It is now being used as an energy wildcard for all problems. But how long will it take to make industrial production sufficiently affordable? With its H2 subsidiary Nucera, ThyssenKrupp will play a major role in the race against global warming.

Read the report


13.04.2023, Author: Nico Popp

USA puts $5 billion into mRNA technology with "NextGEN"

A few days ago, the biotech company Defence Therapeutics announced the launch of its mRNA vaccine program against cancer. The assumption behind this: mRNA vaccines become more effective when combined with Defence Therapeutics' patented drug enhancer Accum™. The Company now wants to test a specially produced mRNA vaccine in its pure form against the combination of mRNA vaccine and Accum™ in a clinical trial. Looking more closely at the challenges of mRNA vaccines, Accum™ could also make other projects more effective and become a sought-after adjuvant technology around mRNA. Find out what is behind it and how great the potential could be.

Read the report


13.04.2023, Author: Stefan Feulner

Berkshire Hathaway divests more shares

In an interview with the business and financial news channel CNBC in Tokyo, investment legend Warren Buffett described the Chinese market leader in electric cars as an "extraordinary company." Nevertheless, Berkshire Hathaway, the investment firm he manages, reduced its stake again, for the tenth time, since last August. The market reaction was enormous, with the stock losing more than 5% at times. The setback offers new opportunities because, fundamentally, everything is going according to plan at BYD.

Read the report


12.04.2023, Author: André Will-Laudien

Record production in 2022

With a gold price of USD 2,032, there was a noticeable jolt through the precious metal community at the beginning of April. This is because the price came very close to the important mark of USD 2,050, the double high from 2020 and 2022. In addition to manifested inflation, poor economic development and emerging crises in the financial sector, there are currently many reasons that speak for higher precious metal prices. Especially in times of political instability, investors are looking for a "catastrophe hedge" in their portfolio. Over the past 25 years, gold has gained 8.6% per annum, offsetting any loss of purchasing power. Now the technical barriers are in place - if they fall, there is no stopping producers like Barrick Gold.

Read the report


12.04.2023, Author: André Will-Laudien

Now the portfolio is picking up

High inflation, geopolitical risks and political upheavals are the breeding ground for rising precious metal prices. A key driver for the rising demand for gold is the price development on the foreign exchange market. Due to the recent disappointing economic data and recent turbulences in the banking sector following the bankruptcy of several regional banks in the US, the US dollar has depreciated significantly. As a result, gold is becoming cheaper on the world market, which is boosting demand. In March 2023, the bankruptcy of Credit Suisse noticeably startled investors and pushed the price of the troy ounce near the old high from 2011. The technical breakout is still to come, but momentum is high and the underlying conditions promise a new cycle for precious metals - good news for Globex Mining's portfolio. Over 200 projects are delivering cash flow and need to be revalued by the market!

Read the report


11.04.2023, Author: Nico Popp

Is Accum™ becoming an mRNA adjuvant technology?

Yesterday after the close of trading in Canada, Defence Therapeutics announced the launch of its mRNA vaccine program against cancer. This will involve combining mRNA molecules with Accum™ technology and will be followed by the comparison of the mRNA-Accum™ combination with naked mRNA. The background to the scientific investigation is that mRNA injected into the body is often destroyed as part of immune responses and other processes. Defence Therapeutics believes these processes are absent when combined with Defence's patented Accum™ technology. We look at what the latest news means, where Defence stands right now and what questions investors still need to be answered concerning the Defence Therapeutics share.

Read the report


11.04.2023, Author: Stefan Feulner

The tourism group faces crucial weeks

Hardly any other sector of the economy was hit as hard by the Corona pandemic as the travel industry and experienced dislocations on an unprecedented scale. Without government rescue packages, the world's largest fully integrated tourism group, TUI, would hardly have survived this crisis of the century. Since the openings and the end of the lockdowns, the number of bookings has increased noticeably. More than 500,000 customers booked a TUI vacation over Easter, and booking numbers are expected to return to pre-Covid levels for the summer. The Group's strategy is clearly defined and focuses operationally on profitable growth in the Vacation Experiences and Markets & Airlines divisions. On the other hand, reducing debt, refinancing and strengthening the balance sheet is at the top of the Hanover-based company's agenda. The ongoing capital increase is now intended to take the first step toward recovery. But questions and uncertainties remain.

Read the report


06.04.2023, Author: Stefan Feulner

After reaching an all-time high, a sharper correction looms

The war in Ukraine has been raging for over a year, and an end is nowhere in sight. On the contrary, while peace talks and a diplomatic solution would be the favored solution for many, politicians continue to focus on armament and the supply of heavy weapons. One of the main beneficiaries is the Düsseldorf-based arms manufacturer Rheinmetall, whose share price has risen by 190% since the start of the Russian invasion and has even made it into Germany's highest stock market segment, the DAX. Despite a consistently good news flow with new orders, partnerships, and the construction of a maintenance center in Romania, the all-time high of EUR 281.30 could no longer be held. Looking at the chart, this could result in a longer correction.

Read the report